drugset / Trial / NCT02544906

Propofol Versus Dexmedetomidine for Prevention of Sevoflurane Agitation in Recipients of Living Donor Liver Transplantation

NCT02544906 ↗

Unknown 120 enrolled AlRefaey Kandeel
RandomizedParallel-groupSingle-blindPrevention

Summary

The use of propofol or dexmedetomedine for prevention of sevofurane emergence agitation in LDLT recipients

Timeline

Start
2015-09
Primary completion
2016-10
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Propofol Small molecule 1 mg/kg —
Subject dexmedetomedine Unknown 0.5 ug/kg —

Indications

No indication recorded.